TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Complexa raises $13M to fund trials of kidney disease drug

Daily Photo Galleries

Wednesday, June 4, 2014, 10:51 a.m.
 

Complexa Inc., a South Side-based drug development company, said it raised $13 million from investors that will fund clinical trials of a drug to treat kidney disease.

The funding round, Complexa's second, was led by Jafco Life Science Investment, an arm of Japanese private equity firm Jafco Co. Ltd.

The company previously raised more than $8 million from venture capital investors to license and develop molecules discovered and patented by professor Bruce Freeman and a team of researchers at the University of Pittsburgh.

There is “great interest” in Complexa's work from large pharmaceutical companies, Jafco officials said in a statement.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Chrysler roars back with latest 200
  2. Range Resources to pay $4.15M fine, close old gas drilling impoundments
  3. Glaxo­SmithKline’s $492M fine is largest in China
  4. Pa. unemployment rate rises to 5.8 percent
  5. FDA revises food safety rules due out next year
  6. Parasitic load issue solvable with some probing
  7. CNG autos slow to make inroads into U.S. market
  8. Ferrari growth would benefit Fiat
  9. Alibaba stock soars in frenetic trading debut
  10. Stocks drift amid Alibaba’s IPO drama
  11. 5 Facebook settings to change now
Subscribe today! Click here for our subscription offers.